AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Phathom Pharmaceuticals, Inc. Director's Dealing 2019

Oct 25, 2019

32407_dirs_2019-10-24_8e499f0f-7a37-44be-b210-7a80e78bc914.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2019-10-24

Reporting Person: Yamada Tadataka (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1686704	Direct

Footnotes

F1: 1,080,545 shares are subject to a right of repurchase by Phathom Pharmaceuticals, Inc.